Compounds > 6-hexadecanoylamino-4-methylumbelliferyl-galactopyranoside
Page last updated: 2024-09-03

6-hexadecanoylamino-4-methylumbelliferyl-galactopyranoside and 4-methylumbelliferyl-galactopyranoside

6-hexadecanoylamino-4-methylumbelliferyl-galactopyranoside has been researched along with 4-methylumbelliferyl-galactopyranoside in 1 studies

Compound Research Comparison

Studies
(6-hexadecanoylamino-4-methylumbelliferyl-galactopyranoside)		Trials
(6-hexadecanoylamino-4-methylumbelliferyl-galactopyranoside)		Recent Studies (post-2010)
(6-hexadecanoylamino-4-methylumbelliferyl-galactopyranoside)		Studies
(4-methylumbelliferyl-galactopyranoside)		Trials
(4-methylumbelliferyl-galactopyranoside)		Recent Studies (post-2010) (4-methylumbelliferyl-galactopyranoside)
6005204

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kolodny, EH; Krivit, W; Kurtzberg, J; Pastores, GM; Raghavan, S; Torres, PA; Zeng, B1

Other Studies

1 other study(ies) available for 6-hexadecanoylamino-4-methylumbelliferyl-galactopyranoside and 4-methylumbelliferyl-galactopyranoside

ArticleYear
Globoid cell leukodystrophy (Krabbe disease): normal umbilical cord blood galactocerebrosidase activity and polymorphic mutations.
    Journal of inherited metabolic disease, 2005, Volume: 28, Issue:6

    Topics: Alleles; Central Nervous System; Cryopreservation; DNA, Complementary; Fetal Blood; Galactosides; Galactosylceramidase; Hematopoietic Stem Cell Transplantation; Heterozygote; HLA Antigens; Homozygote; Humans; Hymecromone; Leukodystrophy, Globoid Cell; Lysosomes; Mutation; Polymorphism, Genetic

2005